BC

Broadfin Capital Portfolio holdings

AUM $403M
1-Year Est. Return 74.97%
This Quarter Est. Return
1 Year Est. Return
+74.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$485M
AUM Growth
-$72.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$28.9M
2
+$25.1M
3
+$18.7M
4
ACRS icon
Aclaris Therapeutics
ACRS
+$13.9M
5
INCY icon
Incyte
INCY
+$11.7M

Top Sells

1
+$22.5M
2
+$18.4M
3
+$13.5M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$11.8M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$8.04M

Sector Composition

1 Healthcare 87.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$5.71M 0.75%
+58,700
27
$5.65M 0.74%
217,136
-1,000
28
$5.26M 0.69%
866,500
+616,500
29
$5.1M 0.67%
84,770
30
$4.78M 0.63%
+129,300
31
$4.67M 0.61%
51,000
32
$4.41M 0.58%
+47,373
33
$4.32M 0.57%
+2,618,819
34
$4.1M 0.54%
+528,571
35
$3.87M 0.51%
282,338
-22,947
36
$3.38M 0.44%
89,100
-483,979
37
$3.31M 0.43%
190,000
+57,400
38
$3.09M 0.41%
119,294
-171,919
39
$2.83M 0.37%
143,129
-6,871
40
$2.67M 0.35%
+351,800
41
$1.66M 0.22%
6,789
-140
42
$1.46M 0.19%
+4,777
43
$1.35M 0.18%
28,652
-8,405
44
$1.03M 0.14%
1,229,301
-719,253
45
$1.03M 0.14%
449,585
-220,227
46
– –
-62,200
47
– –
0
48
– –
-289,035
49
– –
0
50
– –
-2,493,021
1
2
3